Citation 133157

CHANG,CW: LIN,MT: LEE,SS: LIU,KCSC: HSU,FL: LIN,JY:. (1995). DIFFERENTIAL INHIBITION OF REVERSE TRANSCRIPTASE AND CELLULAR DNA POLYMERASE-ALPHA ACTIVITIES BY LIGNANS ISOLATED FROM CHINESE HERBS, PHYLLANTHUS MYRTIFOLIUS MOON, AND TANNINS FROM LONICERA JAPONICA THUNB AND CASTANOPSIS HYSTRIX.. 27(4)

Citation Details

TitleDIFFERENTIAL INHIBITION OF REVERSE TRANSCRIPTASE AND CELLULAR DNA POLYMERASE-ALPHA ACTIVITIES BY LIGNANS ISOLATED FROM CHINESE HERBS, PHYLLANTHUS MYRTIFOLIUS MOON, AND TANNINS FROM LONICERA JAPONICA THUNB AND CASTANOPSIS HYSTRIX.
AuthorsCHANG,CW: LIN,MT: LEE,SS: LIU,KCSC: HSU,FL: LIN,JY:
Year1995
Volume27
Issue4

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHYLLAMYCIN B
ACTIVE
2
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHYLLAMYCIN B
EQUIVOCAL
3
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RETROJUSTICIDIN B
ACTIVE
4
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RETROJUSTICIDIN B
EQUIVOCAL
5
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CHLOROGENIC ACID
INACTIVE
6
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-4-DICAFFEOYL:
ACTIVE
7
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-4-DICAFFEOYL:
ACTIVE
8
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-5-DICAFFEOYL:
ACTIVE
9
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-5-DICAFFEOYL:
ACTIVE
10
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,4-5-DICAFFEOYL:
INACTIVE
11
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,4-5-DICAFFEOYL:
INACTIVE
12
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-4-DICAFFEOYL: METHYL ESTER
WEAK ACTIVITY
13
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-4-DICAFFEOYL: METHYL ESTER
WEAK ACTIVITY
14
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-5-DICAFFEOYL: METHYL ESTER
ACTIVE
15
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-5-DICAFFEOYL: METHYL ESTER
ACTIVE
16
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-O-GALLOYL:
WEAK ACTIVITY
17
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-O-GALLOYL:
WEAK ACTIVITY
18
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,5-O-GALLOYL:
INACTIVE
19
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-4-DI-O-GALLOYL:
WEAK ACTIVITY
20
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-4-DI-O-GALLOYL:
ACTIVE
21
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-5-DI-O-GALLOYL:
ACTIVE
22
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-5-DI-O-GALLOYL:
ACTIVE
23
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-4-5-TRI-O-GALLOYL:
STRONG ACTIVITY
24
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIC ACID,3-4-5-TRI-O-GALLOYL:
ACTIVE
25
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SHIKIMIC ACID,3-O-GALLOYL:
WEAK ACTIVITY
26
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SHIKIMIC ACID,3-O-GALLOYL:
INACTIVE
27
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SHIKIMIC ACID,4-O-GALLOYL:
INACTIVE
28
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SHIKIMIC ACID,5-O-GALLOYL:
INACTIVE
29
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SHIKIMIC ACID,3-4-DI-O-GALLOYL:
ACTIVE
30
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SHIKIMIC ACID,3-4-DI-O-GALLOYL:
ACTIVE
31
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SHIKIMIC ACID,3-5-DI-O-GALLOYL:
STRONG ACTIVITY
32
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SHIKIMIC ACID,3-5-DI-O-GALLOYL:
STRONG ACTIVITY
33
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SHIKIMIC ACID,3-4-5-TRI-O-GALLOYL:
STRONG ACTIVITY
34
DNA POLYMERASE ALPHA INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SHIKIMIC ACID,3-4-5-TRI-O-GALLOYL:
STRONG ACTIVITY
35
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
JUSTICIDIN A
WEAK ACTIVITY
36
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
JUSTICIDIN B
EQUIVOCAL
37
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHYLLAMYCIN A
WEAK ACTIVITY
38
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHYLLAMYCIN C
INACTIVE
Show SPARQL Queries (1)